NAB2 and leukemia: The exact mechanism by which NAB2 modulates the transcriptional activity of WT1 remains to be investigated, but our data indicate that NAB2 can counteract the repressive effect of WT1 on the leukemic suppressor gene IRF8, suggesting that NAB2 potentially could modulate the oncogenic effects by WT1 in leukemia.